Cargando…
Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664825/ https://www.ncbi.nlm.nih.gov/pubmed/33237247 http://dx.doi.org/10.31744/einstein_journal/2020CE5754 |
| _version_ | 1783609899502010368 |
|---|---|
| author | Pinto, Charleston Ribeiro Costa, Lindemberg Assunção Lemos, Antônio Carlos Moreira Martins, Eduardo |
| author_facet | Pinto, Charleston Ribeiro Costa, Lindemberg Assunção Lemos, Antônio Carlos Moreira Martins, Eduardo |
| author_sort | Pinto, Charleston Ribeiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7664825 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Instituto Israelita de Ensino e Pesquisa Albert Einstein |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76648252020-11-20 Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System Pinto, Charleston Ribeiro Costa, Lindemberg Assunção Lemos, Antônio Carlos Moreira Martins, Eduardo Einstein (Sao Paulo) Letter to the Editor Instituto Israelita de Ensino e Pesquisa Albert Einstein 2020-11-12 /pmc/articles/PMC7664825/ /pubmed/33237247 http://dx.doi.org/10.31744/einstein_journal/2020CE5754 Text en https://creativecommons.org/licenses/by/4.0/ This content is licensed under a Creative Commons Attribution 4.0 International License. |
| spellingShingle | Letter to the Editor Pinto, Charleston Ribeiro Costa, Lindemberg Assunção Lemos, Antônio Carlos Moreira Martins, Eduardo Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System |
| title | Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System |
| title_full | Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System |
| title_fullStr | Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System |
| title_full_unstemmed | Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System |
| title_short | Evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the Brazilian Public Health System |
| title_sort | evidence that justifies reviewing policies of access to medicines for chronic obstructive pulmonary disease in the brazilian public health system |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664825/ https://www.ncbi.nlm.nih.gov/pubmed/33237247 http://dx.doi.org/10.31744/einstein_journal/2020CE5754 |
| work_keys_str_mv | AT pintocharlestonribeiro evidencethatjustifiesreviewingpoliciesofaccesstomedicinesforchronicobstructivepulmonarydiseaseinthebrazilianpublichealthsystem AT costalindembergassuncao evidencethatjustifiesreviewingpoliciesofaccesstomedicinesforchronicobstructivepulmonarydiseaseinthebrazilianpublichealthsystem AT lemosantoniocarlosmoreira evidencethatjustifiesreviewingpoliciesofaccesstomedicinesforchronicobstructivepulmonarydiseaseinthebrazilianpublichealthsystem AT martinseduardo evidencethatjustifiesreviewingpoliciesofaccesstomedicinesforchronicobstructivepulmonarydiseaseinthebrazilianpublichealthsystem |